Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Advanced Therapy Medicinal Products Market By 2029?
The advanced therapy medicinal products market has seen rapid expansion in recent years. It is projected to increase from $42.85 billion in 2024 to $51.34 billion in 2025, reflecting a compound annual growth rate (CAGR) of 19.8%. This historical growth can be attributed to several factors: an increasing volume of clinical trials for gene and cell therapies, a rising incidence of rare and genetic disorders, a growing demand for curative treatments rather than chronic disease management, enhanced success rates in early-phase clinical studies, and a greater prevalence of chronic and age-related conditions.
The advanced therapy medicinal products market size is anticipated to experience rapid expansion over the next few years, projected to grow to $104.43 billion in 2029, at a compound annual growth rate (CAGR) of 19.4%. This growth during the forecast period is fueled by an increasing demand for personalized and precision medicine approaches, a growing number of chimeric antigen receptor t-cell and gene-editing therapies in development, the rising adoption of precision medicine and genomics, increasing healthcare spending in emerging markets, and a greater focus on decentralized clinical trial models. Significant trends expected in the forecast period include the development of allogeneic off-the-shelf therapies, the creation of non-viral gene delivery vectors, the integration of digital twins in therapy simulation, the incorporation of blockchain in supply chain tracking, and innovations in 3D bioprinting for tissue engineering.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25689&type=smp
Which Factors And Drivers Are Influencing The Advanced Therapy Medicinal Products Market In 2025?
The advanced therapy medicinal products market is expected to experience growth due to the increasing requirement for personalized medicine. Personalized medicine represents a medical approach focused on customizing treatment and prevention strategies to an individual’s distinct genetic makeup, lifestyle, and environment. The growing need for personalized medicine primarily stems from the rising occurrence of chronic illnesses, as it allows for tailored treatments that enhance patient outcomes and minimize side effects for individual patients. Advanced therapy medicinal products support personalized medicine by offering specialized treatments, such as gene, cell, and tissue-engineered therapies, which target the unique genetic and biological characteristics of individual patients. As of February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA gave approval to 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also featured seven cancer drugs and three for other diseases and conditions. Thus, the escalating demand for personalized medicine is a key factor driving the expansion of the advanced therapy medicinal products market.
How Is The Advanced Therapy Medicinal Products Market Segmented?
The advanced therapy medicinal products market covered in this report is segmented –
1) By Product: Somatic Cell Therapy Medicinal Products, Tissue Engineered Medicinal Products, Gene Therapy Medicinal Products
2) By Technology: Gene Editing Technologies, Viral Vector Technology, Stem Cell Technology, Automation And Artificial Intelligence-Driven Processes
3) By Application: Muscular Dystrophies, Alzheimer’s, Hemophilia, Cystic Fibrosis, Other Applications
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Somatic Cell Therapy Medicinal Products: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy, Natural Killer Cell Therapy
2) By Tissue Engineered Medicinal Products: Autologous Tissue-Engineered Products, Allogeneic Tissue-Engineered Products, Scaffold-Based Tissue Engineering, Scaffold-Free Tissue Engineering, Skin Substitutes
3) By Gene Therapy Medicinal Products: In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Gene Editing Therapies
Which Key Trends Are Expected To Influence The Advanced Therapy Medicinal Products Market In The Coming Years?
Leading companies in the advanced therapy medicinal products market are concentrating on innovative treatments, such as novel CAR-T cell therapies, to enhance outcomes for cancer and other serious diseases. CAR-T cell therapies are sophisticated cancer interventions that utilize a patient’s own T cells, which are genetically modified to identify and eliminate cancer cells. For example, in May 2022, Novartis AG, a Switzerland-based pharmaceutical company, obtained approval from the U.S. Food and Drug Administration (FDA) for Kymriah, a CAR-T cell therapy designed to treat adult patients with relapsed or refractory follicular lymphoma (FL) after two or more prior systemic treatments. This therapy involves employing the patient’s own T cells, genetically engineered to express a chimeric antigen receptor (CAR) specifically targeting the cd19 protein. This alteration allows the T cells to recognize and destroy malignant B cells. Kymriah also includes a 4-1BB costimulatory domain, which supports T cell expansion and persistence, leading to sustained antitumor effects from a single infusion.
Which Leading Companies Dominate The Advanced Therapy Medicinal Products Market Share?
Major companies operating in the advanced therapy medicinal products market are F. Hoffmann-La Roche Limited., Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited., Lonza Group AG, Catalent Inc., BioMarin Pharmaceutical Inc., AGC Biologics Inc., ViaCyte Inc., Rentschler Biopharma SE, JCR Pharmaceuticals Co. Ltd., Vericel Corporation, UniQure N.V., Fate Therapeutics Inc., WuXi Advanced Therapies Inc., Celonic Group AG, Pharmicell Co. Ltd., Magenta Therapeutics Inc, MEDIPOST Co. Ltd., Kolon TissueGene Inc
Download The Full Report For Exclusive Market Findings:
How Does The Advanced Therapy Medicinal Products Market Perform Across Key Geographic Regions?
North America was the largest region in the advanced therapy medicinal products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Advanced Therapy Medicinal Products Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25689&type=smp
Browse Through More Reports Similar to the Global Advanced Therapy Medicinal Products Market 2025, By The Business Research Company
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Global Market Report 2025
Herbal Medicine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/herbal-medicine-global-market-report
Anti Inflammatory Therapeutics Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model